| 书目名称 | Management of Chemotherapy-Induced Nausea and Vomiting |
| 副标题 | New Agents and New U |
| 编辑 | Rudolph M. Navari |
| 视频video | |
| 概述 | Provides a comprehensive review of the new agents for treatment of chemotherapy-induced nausea and vomiting.Provides a detailed description of new uses of current agents for treatment of chemotherapy- |
| 图书封面 |  |
| 描述 | This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings..CINV is one of the most feared treatment related toxicities. Patient surveys for the past thirty years consistently demonstrate patients’ perception of deterioration in quality of life due to chemotherapy treatments. The introduction of the antiemetics, serotonin 5-HT3 receptor antagonists and the neurokinin-1 receptor antagonists, have improved the control of chemotherapy-induced emesis, but the treatment of chemotherapy-induced nausea remains a significant clinical problem. Patients continue to have quality of life issues which prevent normal functioning during active treatment. New agents such as the second generation 5-HT3 receptor antagonist palonosetron and the new neuroknin-1 receptor antagonists rolapitant and netupitant are being introduced into clinical practice, and it |
| 出版日期 | Book 2016 |
| 关键词 | 5-Hyroxytryptamine-3 Receptor Antagonists; Anti-emetics; Dexamethasone; Gabapentin; Multi-day Chemothera |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-319-27016-6 |
| isbn_softcover | 978-3-319-80058-5 |
| isbn_ebook | 978-3-319-27016-6 |
| copyright | Springer International Publishing Switzerland 2016 |
发表于 2025-3-21 17:59:02
